ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 8–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Oct 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
November 2025
Nuclear Technology
Fusion Science and Technology
Latest News
NextEra and Google ink a deal to restart Duane Arnold
A day anticipated by many across the nuclear community has finally arrived: NextEra Energy has officially announced its plans to restart Iowa’s only nuclear power plant, the Duane Arnold Energy Center.
Tae Young Kong, Gamal Akabani, John W. Poston, Sr.
Nuclear Technology | Volume 205 | Number 6 | June 2019 | Pages 781-789
Technical Paper | doi.org/10.1080/00295450.2018.1546536
Articles are hosted by Taylor and Francis Online.
The 2007 Recommendation of the International Commission on Radiological Protection [ICRP Publication 103, Elsevier (2007)] requires implementation of the concept of a dose constraint for members of the public living around nuclear facilities. Under the paradigm of regulatory science, the use of dose constraints is still highly debatable. This study determines whether a dose constraint is necessary for members of the public living near U.S. nuclear power plants (NPPs) using data from the years 2007 to 2009, which were provided by the Nuclear Regulatory Commission. As a result of analysis of exposure data, it is concluded that a dose constraint is not necessary for members of the public living around U.S. NPPs and that such a constraint may place an unnecessary regulatory burden on the licensees.